Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
ROPINIROLE HYDROCHLORIDE
Accord Healthcare Limited
ROPINIROLE HYDROCHLORIDE
0.5 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
PACKAGE LEAFLET: INFORMATION FOR THE USER INVENTED NAME ROPINIROLE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORATANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, please ask your doctor, pharmacist or nurse. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What is Ropinirole Accord and what it is used for 2. What you need to know before you take Ropinirole Accord 3. How to take Ropinirole Accord 4. Possible side effects 5. How to store Ropinirole Accord 6. Contents of the pack and other information 1. WHAT IS ROPINIROLE ACCORD AND WHAT IT IS USED FOR The active substance in Ropinirole Accord is ropinirole which belongs to a group of medicines called dopamine agonists. Dopamine agonists affect the brain in a similar way to a natural substance dopamine. Ropinirole Accord is used to treat Parkinson's disease. People with Parkinson's disease have low concentrations of dopamine in some parts of their brains. Ropinirole has similar effects to those of natural dopamine, so it helps to reduce the symptoms of Parkinson’s disease. Ropinirole Accord is used to treat the symptoms of moderate to severe Restless Legs Syndrome. Patients with moderate to severe Restless Legs Syndrome generally complain of trouble sleeping or severe discomfort in the legs or arms. Patients with Restless Legs Syndrome have an irresistible urge to move their legs,and sometimes their arms and other parts of their body. They usually have an uncomfortable feeling in the legs (sometimes described as pins and needles, burnin Baca dokumen lengkapnya
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ropinirole 0.5 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 0.50 mg Ropinirole (as hydrochloride). Excipient (s) with known effect: Each 0.50 mg film-coated tablet contains 48.43 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Round biconvex, plain on both sides, yellow. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of Parkinson’s disease under the following conditions: Initial treatment as monotherapy, in order to delay the introduction of levodopa. In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur ("end of dose" or "on-off" type fluctuations). Symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral use. PARKINSON’S DISEASE Adults Individual dose titration against efficacy and tolerability is recommended. Ropinirole tablets should be taken three times a day, preferably with meals to improve gastrointestinal tolerance. _Treatment initiation_ The initial dose of ropinirole should be 0.25 mg three times daily for 1 week. Thereafter, the dose of ropinirole can be increased in 0.25 mg three times daily increments, according to the following regimen: _Therapeutic regimen_ After the initial titration, weekly increments of 0.5 to 1 mg three times daily (1.5 to 3 mg/day) of ropinirole may be given. Week 1 2 3 4 Unit dose (mg) of ropinirole 0.25 0.5 0.75 1.0 Total daily dose (mg) of ropinirole 0.75 1.5 2.25 3.0 IRISH MEDICINES BOARD ___________________________________________________________________ Baca dokumen lengkapnya